Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
02 Jun, 2026, 07.31 PM IST
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
02 Jun, 2026, 09.53 AM IST
AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
01 Jun, 2026, 05.01 PM IST
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
01 Jun, 2026, 10.11 AM IST
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
01 Jun, 2026, 07.44 AM IST
What to know about the outbreak of a rare kind of Ebola as cases outpace responseA rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...
31 May, 2026, 07.43 PM IST
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
31 May, 2026, 05.38 PM IST
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
29 May, 2026, 06.56 PM IST
How to identify Gaboon Viper: Key physical features, range, habitat, and dietAfrica's Gaboon viper boasts the longest fangs of any venomous snake. This master of camouflage lives in forests and is a patient hunter. W...
29 May, 2026, 03.22 PM IST
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
29 May, 2026, 11.05 AM IST
Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
28 May, 2026, 11.52 AM IST
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
27 May, 2026, 08.27 PM IST
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
27 May, 2026, 12.24 PM IST
Health services, medical education expansion to be driven by modern tech: Yogi AdityanathUttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding s...
26 May, 2026, 04.34 PM IST
Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
14 May, 2026, 02.09 PM IST